13F-NT filed by Gilead Therapeutics A1 Unlimited Co
Gilead Therapeutics A1 Unlimited Co filed this 13F-NT for the quarter ended 2026-03-31, filed 2026-05-08.
- Accession
- 0001123292-26-000643
- Filer
- CIK 2055207
- Filed
- 2026-05-08
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A notice, 13F file number 028-25083. A notice: the holdings are in another manager's report. The resolved quarter.
Other managers
- reports for this filerGilead Sciences, Inc.028-25078
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-NT 0001123292-26-000643 | this filing | 2026-05-08 | acceptance time not in the bulk data set |